EVERBIZ News Center: company news, global medical device regulatory updates, and registration and compliance insights.


Thailand Fast-Tracks Medical Device Changes: Changes Already Approved Abroad Cleared in as Little as 15 Working Days
The Thai FDA has introduced a fast track for change applications: if the same change has already been approved in a reference country such as the US or EU, minor and major changes to Class 2–4 devices can be approved in as little as 15 working days without external expert review. We explain the conditions,…


CFDI Publishes Key Inspection Points for AI Medical Devices: Quality System Inspections No Longer Stop at the Workshop
China’s CFDI has published Key Inspection Points for AI medical devices, bringing the whole chain from data and algorithms to delivery and post-market into the QMS with 14 key risk points. We explain the six most important new requirements, what companies should do now, and how this compares with EU MDR/IVDR and the AI Act.


FDA 510(k) Premarket Notification Explained: What Device Manufacturers Need to Get Right Before Entering the US
A 510(k) must demonstrate substantial equivalence to a legally marketed predicate device, and submitting it does not allow you to sell: the device may only be marketed after FDA issues a written clearance. We outline when 510(k) applies and three practical steps.


Hong Kong Updates RS-01 Recognised Standards List for the First Time in Five Years: New AI Section Includes 10 Chinese YY/T Standards
Hong Kong’s Medical Device Division published RS-01:2026(E) on 29 October 2026, effective the same day. A new Section 3.9 on artificial intelligence lists 12 standards, 10 of them Chinese YY/T standards. No transition period or deadline was set.


China Issues GMP Inspection Guideline for Standalone Software: Compliance Now Has to Show in Every Release
On 30 October 2026 China’s NMPA issued the GMP inspection guideline for standalone medical device software, effective 1 November 2026. Software manufacturers can start their self-inspection by tracing one real release from requirement to delivery.


China Issues 4 GMP Inspection Guidelines for Sterile, Implantable, IVD and Custom-made Denture Devices, Effective 1 November 2026
From 1 November 2026, China’s NMPA will assess inspections of sterile, implantable, IVD and custom-made denture devices against four new GMP inspection guidelines, replacing the 2015/2016 on-site guidelines with no transition period.


EU MDR/IVDR “Simplification” Update: Adoption Targeted for Mid-2027 – Current Rules and Transition Deadlines Unchanged
The EU aims to adopt the MDR/IVDR amendments around summer 2027, but the proposal is not yet law: current rules, transition deadlines and EUDAMED obligations all still apply.


FDA QMSR Eight Months In: Why an ISO 13485 Certificate Is Not Enough
The QMSR builds on ISO 13485, but FDA-specific requirements still apply — plus an MDSAP roadmap and a self-check list.


Indonesia’s KMK 951/2026 Takes Effect: Imported AI Software Needs Local Clinical Validation
Indonesia’s new software and AI medical device guidelines apply immediately, with local clinical validation for imported AI.


UK Confirms Indefinite Recognition of CE-Marked Medical Devices: Good News, but 5 UK Obligations Remain
The UK will indefinitely recognise EU MDR / IVDR CE-marked devices — but UK local obligations remain.


45 Days to Go: EUDAMED Registration of Existing Devices Closes on 28 November – Is Your Product Registered?
EVERBIZ | EU MDR/IVDR Regulatory Update On 28 May 2026, the first four modules of the European database on medical devices, EUDAMED, became mandatory. Many companies breathed a sigh of relief after registering their new products, but it is easy to overlook the second milestone that follows – 28 November 2026: the deadline for registering…


China Issues New Medical Device GMP Inspection Guidelines: 200 Items in Three Risk Levels from 1 November
The new medical device GMP inspection guidelines take effect on 1 November, with 200 inspection items graded at three levels. Here are the key points.